stockrowSchrodinger, Inc.
SDGR Healthcare Health Information Services
Schrodinger, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $255.9 million, up 23.3% from fiscal 2024.
- Revenue
- +18.7%
- EPS
- −11.1%
- Free cash flow
- +21.6%
Quarter to September 2026, against a year earlier
Follow SDGR
Alert me
Schrodinger, Inc. (SDGR) Shares outstanding
Schrodinger, Inc.'s shares outstanding at the end of fiscal 2025 was $73.4M, unchanged from fiscal 2024. At the end of the quarter to 30 September 2026 it was $74.9M. Over the past ten years it has ranged from $5.8M (fiscal 2018) to $75.0M (fiscal 2023); the current reading is higher than 89% of that period. Schrodinger, Inc. ranks 19th of 43 Health Information Services companies by shares outstanding.
Shares outstanding, annual
Embed this chart
Annual newest first
| Period | Shares outstanding | Change |
|---|---|---|
| FY2025 | $73.4M | 1.06% |
| FY2024 | $72.7M | (3.09%) |
| FY2023 | $75.0M | 5.36% |
| FY2022 | $71.2M | 0.82% |
| FY2021 | $70.6M | 17.61% |
| FY2020 | $60.0M | 899.58% |
| FY2019 | $6.0M | 4.05% |
| FY2018 | $5.8M | (90.88%) |
| FY2017 | $63.3M | — |
Quarterly newest first
| Period | Shares outstanding | Change |
|---|---|---|
| Sep 2026 | $74.9M | (1.19%) |
| Jun 2026 | $75.8M | 2.41% |
| Mar 2026 | $74.0M | 0.74% |
| Dec 2025 | $73.4M | (0.23%) |
| 27 more quarters | Free account |
Against its own ten years
Shares outstanding against peers
| Company | Shares outstanding |
|---|---|
| GDRX GoodRx Holdings, Inc. compare | $348.1M |
| TDOC Teladoc Health, Inc. compare | $181.9M |
| CERT Certara, Inc. compare | $152.7M |
| PRVA Privia Health Group, Inc. compare | $132.7M |
| HTFL Heartflow, Inc. compare | $86.4M |
| SDGR Schrodinger, Inc. | $74.9M |
| OMDA Omada Health, Inc. compare | $63.9M |
| OMCL Omnicell, Inc. compare | $46.5M |
| HSTM HealthStream, Inc. compare | $29.7M |
What Shares outstanding is
Shares (Diluted, Weighted) tells an investor how many shares a company’s earnings are spread across once potential new shares are counted.
Reported line item
More on SDGR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement